Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Murray Baron

Showing results (151-160 of 281) with videos related to

Pageof 29
Sort By:
Arthritis Care & Research|November 7, 2022
Patient and Physician Global Assessments of Disease Status in Systemic SclerosisLaura Ross, Mandana Nikpour, Julie D'Aoust, et al.
Rheumatology (Oxford, England)|December 6, 2018
Severe gastrointestinal disease in very early systemic sclerosis is associated with early mortalityNicolas Richard, Marie Hudson, Mianbo Wang, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 27, 2024
Development and Initial Validation of the Novel Scleroderma Clinical Trials Consortium Activity IndexLaura Ross, Dylan Hansen, Susanna Proudman, et al.
The Journal of Rheumatology|September 17, 2010
Discordance between patient and physician assessments of disease severity in systemic sclerosisMarie Hudson, Ann Impens, Murray Baron, et al.
Journal of Scleroderma and Related Disorders|April 6, 2022
Mammalian target of rapamycin is activated in the kidneys of patients with scleroderma renal crisisJessica Salituri, Natalie Patey, Tomoko Takano, et al.
Arthritis Care & Research|February 28, 2022
Damage Trajectories in Systemic Sclerosis Using Group-Based Trajectory ModelingAriane Barbacki, Murray Baron, Mianbo Wang, et al.
Autoimmunity Reviews|January 26, 2018
Bicaudal D2 is a novel autoantibody target in systemic sclerosis that shares a key epitope with CENP-A but has a distinct clinical phenotypeMarvin J Fritzler, Marie Hudson, May Y Choi, et al.
Arthritis Care & Research|July 29, 2010
Development and validation of the brief-satisfaction with appearance scale for systemic sclerosisLisa R Jewett, Marie Hudson, Jennifer A Haythornthwaite, et al.
Seminars in Arthritis and Rheumatism|August 17, 2014
Absence of an association between anti-Ro antibodies and prolonged QTc interval in systemic sclerosis: a multicenter study of 689 patientsCharles Massie, Marie Hudson, Solène Tatibouet, et al.
The Journal of Rheumatology|November 15, 2022
Evaluation of Patient and Physician Assessments of Gastrointestinal Disease Activity in Systemic SclerosisLaura Ross, Susanna Proudman, Jennifer Walker, et al.
Pageof 29

Showing results (151-160 of 281) with videos related to

Sort By:
Pageof 29
Arthritis Care & Research|November 7, 2022
Patient and Physician Global Assessments of Disease Status in Systemic SclerosisLaura Ross, Mandana Nikpour, Julie D'Aoust, et al.
Rheumatology (Oxford, England)|December 6, 2018
Severe gastrointestinal disease in very early systemic sclerosis is associated with early mortalityNicolas Richard, Marie Hudson, Mianbo Wang, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 27, 2024
Development and Initial Validation of the Novel Scleroderma Clinical Trials Consortium Activity IndexLaura Ross, Dylan Hansen, Susanna Proudman, et al.
The Journal of Rheumatology|September 17, 2010
Discordance between patient and physician assessments of disease severity in systemic sclerosisMarie Hudson, Ann Impens, Murray Baron, et al.
Journal of Scleroderma and Related Disorders|April 6, 2022
Mammalian target of rapamycin is activated in the kidneys of patients with scleroderma renal crisisJessica Salituri, Natalie Patey, Tomoko Takano, et al.
Arthritis Care & Research|February 28, 2022
Damage Trajectories in Systemic Sclerosis Using Group-Based Trajectory ModelingAriane Barbacki, Murray Baron, Mianbo Wang, et al.
Autoimmunity Reviews|January 26, 2018
Bicaudal D2 is a novel autoantibody target in systemic sclerosis that shares a key epitope with CENP-A but has a distinct clinical phenotypeMarvin J Fritzler, Marie Hudson, May Y Choi, et al.
Arthritis Care & Research|July 29, 2010
Development and validation of the brief-satisfaction with appearance scale for systemic sclerosisLisa R Jewett, Marie Hudson, Jennifer A Haythornthwaite, et al.
Seminars in Arthritis and Rheumatism|August 17, 2014
Absence of an association between anti-Ro antibodies and prolonged QTc interval in systemic sclerosis: a multicenter study of 689 patientsCharles Massie, Marie Hudson, Solène Tatibouet, et al.
The Journal of Rheumatology|November 15, 2022
Evaluation of Patient and Physician Assessments of Gastrointestinal Disease Activity in Systemic SclerosisLaura Ross, Susanna Proudman, Jennifer Walker, et al.
Pageof 29